Fifth Third Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.35M Sell
9,260
-224
-2% -$76.7K 0.09% 152
2026
Q1
$3.34M Buy
9,484
+190
+2% +$67.7K 0.11% 143
2025
Q4
$3.04M Buy
9,294
+26
+0.3% +$8.25K 0.11% 137
2025
Q3
$2.62M Buy
9,268
+845
+10% +$245K 0.1% 136
2025
Q2
$2.35M Buy
8,423
+2,238
+36% +$634K 0.1% 141
2025
Q1
$1.93M Buy
6,185
+1,647
+36% +$486K 0.1% 142
2024
Q4
$1.18M Buy
4,538
+204
+5% +$60.5K 0.06% 187
2024
Q3
$1.4M Buy
4,334
+922
+27% +$302K 0.09% 152
2024
Q2
$1.07M Buy
3,412
+1,132
+50% +$333K 0.08% 155
2024
Q1
$648K Buy
2,280
+1,357
+147% +$397K 0.1% 136
2023
Q4
$266K Buy
923
+38
+4% +$10.4K 0.09% 157
2023
Q3
$238K Buy
+885
New +$221K 0.1% 152

Other funds holding AMGN

Fifth Third Wealth Advisors's AMGN Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $76.7K and leaving 9,260 shares worth $3.35M. The position accounts for 0.09% of the portfolio, ranked #152.

Fifth Third Wealth Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 658 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fifth Third Wealth Advisors held 9,260 shares of Amgen worth $3.35M as of Q2 2026.
  • Fifth Third Wealth Advisors sold 224 Amgen shares in Q2 2026, an estimated $76.7K.
  • Amgen made up 0.09% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #152 holding.
  • Fifth Third Wealth Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 658 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.